Nicox, Bausch + Lomb deal

Nicox exercised its option to co-promote latanoprostene bunod ( NCX 116) in the U.S. under a 2010 deal with the Bausch + Lomb Inc. division of Valeant Pharmaceuticals International Inc. (TSX:VRX; NY...